Karen L. Zaderej, Director at EyePoint Pharmaceuticals, Inc. (EYPT), bought 10,000 shares at $5.47 ($54K) on 2025-05-15, disclosed to the SEC on 2025-05-15.
Open-market purchase of $54k EYPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.42 | 5,000 | $27K | 49.8% |
| 2 | $5.47 | 5,000 | $27K | 50.2% |
| Total | $5.45 avg | 10,000 | $54K | 100% |
| Filing → |
| EYPT | BUY | 2024-08-21 | $100K | — | Filing → |
| AXGN | SELL | 2024-03-25 | $555K | — | Filing → |
| AXGN | SELL | 2021-08-10 | $1.5M | — | Filing → |